Yale University

Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.

TitleDisease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Publication TypeJournal Article
Year of Publication2004
AuthorsJustice, Amy C., Daniel S. Stein, Gregory P. Fusco, Beth H. Sherrill, Jennifer S. Fusco, Susan C. Danehower, Stephen L. Becker, Nellie I. Hansen, and Neil M. H. Graham
Corporate AuthorsCHORUS Program Team
JournalJournal of clinical epidemiology
Volume57
Issue1
Pagination89-97
Date Published2004 Jan
ISSN0895-4356
KeywordsAcquired Immunodeficiency Syndrome, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Databases, Factual, Disease Progression, Disease-Free Survival, Follow-Up Studies, HIV Infections, HIV Wasting Syndrome, Humans, Proportional Hazards Models, Prospective Studies, Reverse Transcriptase Inhibitors, Stavudine, Zidovudine
AbstractThis prospective, observational study compared disease progression and death in HIV-1 patients treated with stavudine vs. zidovudine in the Collaborations in HIV Outcomes Research/U.S. (CHORUS) cohort.
DOI10.1016/S0895-4356(03)00245-2
Alternate JournalJ Clin Epidemiol

External Links